Draft Program

13 APRIL 2019

08.00 - 08.10 Introduction - Hagop Kantarjian, Elias Jabbour, Birol Güvenç, Giuseppe Saglio

AML Session

Chairs: Osman İlhan - Moshe Mittelman

08.10 - 08.30 How I Treat AML - Farhad Ravandi

08.30 - 08.50 Biology of AML and BCL2-inhibitors - Marina Konopleva

08.50 - 09.10 MRD Eradication and Role of Maintenance Therapy in AML - Tapan Kadia

09.10 - 09.30 Novel Agents in AML - Farhad Ravandi

09.30 - 09.50 Management of Elderly AML - Tapan Kadia

09.50 - 10.00 Panel Discussion - Chair: Zafer Gülbaş

10.00 - 10.20 Coffee Break

ALL Session

Chairs: Levent Ündar - Mehmet Sönmez

10.20 - 10.40 Biology of ALL - Marina Konopleva

10.40 - 11.10 Frontline Therapy of ALL - Hagop Kantarjian

11.10 - 11.30 MRD Assessment and Management - Farhad Ravandi

11.30 - 12.00 Management of Relapsed/Refractory ALL - Elias Jabbour

12.00 - 12.10 Panel Discussion Chair: Oktay Bilgir

12.10 - 13.00 Lunch

MM Session

Chairs : Ali Ünal - Boris Afanasyev

13.00 - 13.30 Evolving Treatment Paradigm in MM - Joseph Mikhael

13.30 - 13.50 Bite Immunotherapy in Myeloma - Karim Iskander

13.50 - 14.10 Managing Bone Disease in MM - Evangelos Terpos

14.10 - 14.40 Treatment of RRMM - Case Presentations - Jesus San Miguel

14.40 - 14.50 Panel Discussion Chair: Zahit Bolaman

14.50 - 15.10 Coffee Break

CML Session

Chairs: Mehmet Turgut - Iryna Dyagil

15.10 - 15.30 Frontline CML Management - Hagop Kantarjian

15.30 - 15.50 Management of Relapsed/Refractory CML and Advanced Phases - Elias Jabbour

15.50 - 16.10 Treatment-free Remission Where and When? Giuseppe Saglio

16.10 - 16.20 Panel Discussion Chair: Ahmet Ifran

MDS Session

Chairs: Deniz Sargın - Andrey Zaritskey

16.20 - 16.40 Biology and Staging Systems - Guillermo Garcia-Manero

16.40 - 17.00 Management of Higher-Risk MDS - Tapan Kadia

17.00 - 17.20 Management of Lower-Risk MDS - Guillermo Garcia-Manero

17.20 - 17.30 Panel Discussion Chair: Mehmet Yılmaz

17.30 - 17.40 Day 1 Closing Remarks

14 APRIL 2019

CLL Session

Chairs: - Mehmet Ali Özcan - Igor Aurer

08.00 - 08.30 How I Treat Frontline CLL: State of the Art - Susan O’Brien

08.30 - 09.00 Management of Relapsed/Refractory Disease: Novel Agents - Susan O’Brien

09.00 - 09.30 MRD: Assesment & Impact on Survival - Panayiotis Panayiotidis

09.30 - 09.40 Panel Discussion Chair: Burhan Turgut

Lymphoma Session

Chairs: Ayşe Tülin Tuğlular - Ali Bazerbashi

09.40 - 10.00 How I Treat Follicular Lymphoma - Nathan Fowler

10.00 - 10.20 How I Treat Large Cell Lymphoma - Panayiotis Panayiotidis

10.20 - 10.40 How I Treat Hodgkin Disease - Nathan Fowler

10.40 - 11.00 How I Treat Mantle Cell and Marginal Zone Lymphoma - Panayiotis Panayiotidis

11.00 - 11.10 Panel Discussion Chair: Emin Kaya

11.10 - 11.30 Coffee Break

MPN Session

Chairs: Rıdvan Ali- Rajko Kušec

11.30 - 11.50 How I Treat MF - Haifa Katrin Al Ali

11.50 - 12.10 How I Treat PV - Haifa Katrin Al Ali Novartis Satellite

12.10 - 12.20 Panel Discussion Chair: Ferit Avcu

12.20 - 12.30 Rational Drug Use - Chair: Şehmus Ertop Speaker: Birol Güvenç

12.30 - 12.45 Closing Remarks